Alliance QUANTUM Trial to Study Bispecific Immunotherapy for Rare Leukemia
New trial evaluates whether post-transplant consolidation therapy with teclistamab can improve survival in patients with primary plasma cell leukemia

July 30, 2026- The Alliance for Clinical Trials in Oncology today announced the activation of The QUANTUM Trial (Alliance A062401), a clinical study designed to test a novel, immune-targeting approach for patients newly diagnosed with primary plasma cell leukemia (P

• Read more

Nominate an Alliance Unsung Hero by August 28 for the Schilsky Achievement Award

July 29, 2026 - Nominations are due Friday, August 28 for the 2026 Richard L. Schilsky CALGB Achievement Award. This is your chance to identify and honor the “unsung heroes” of the Alliance.

The Richard L. Schilsky Cancer and Leukemia Group B Achievement Award acknowledges the significant contributions of an individual to cooperative group research. As an organization, Alliance loves to i

• Read more

Alliance Expands Social Media Presence to BlueSky, Instagram and Threads

July 21, 2026 - To ensure life-saving cancer research reaches every community that needs it, the Alliance for Clinical Trials in Oncology has expanded its digital footprint beyond Facebook, X (Twitter), LinkedIn, and YouTube. By establishing dedicated presences on Bluesky, Instagram, and Threads, the Alliance is dramatically expanding its reach to help connect with additional investigators, patient advocates and

• Read more